Hans Ehrsson

Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds

Anne-Barbara Witte, Karin Anestål, Elin Jerremalm et al. · Free Radical Biology and Medicine · 2005 · 225 citations

Life Sciences, Biochemistry, Oncology +13

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

Moustapha Hassan, Göran Berg, Hans Ehrsson et al. · European Journal of Clinical Pharmacology · 1989 · 161 citations

Pharmacy, Pharmacokinetics, Pharmacology +6

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

Moustapha Hassan, Göran Berg, A N Békássy et al. · Cancer Chemotherapy and Pharmacology · 1991 · 155 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Pharmacokinetics of Oxaliplatin in Humans

Hans Ehrsson, Inger Wallin, Jeffrey Yachnin · Medical Oncology · 2002 · 116 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +8

Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity

Victoria Hellberg, Inger Wallin, Sven V. Eriksson et al. · JNCI Journal of the National Cancer Institute · 2008 · 111 citations · Full text

Medicine, Oncology, Pharmacology +15